Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cure Pharmaceutical Holding Corp
(OP:
CURR
)
0.1350
+0.0050 (+3.85%)
Streaming Delayed Price
Updated: 9:30 AM EDT, May 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,050
Open
0.1350
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1300
Today's Range
0.1350 - 0.1350
52wk Range
0.0811 - 0.4250
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Avenir Wellness Solutions Update to Stockholders
May 17, 2023
Via
ACCESSWIRE
Wide Marketing and Shipments Commenced for New Patent Pending DNA Complex Skin Care Used by Top Movie and TV Star Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
May 02, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Performance
YTD
-3.57%
-3.57%
1 Month
+3.85%
+3.85%
3 Month
-1.82%
-1.82%
6 Month
-15.89%
-15.89%
1 Year
-57.73%
-57.73%
More News
Read More
Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
April 26, 2023
Via
ACCESSWIRE
Avenir Wellness Letter to Stockholders
April 25, 2023
Via
ACCESSWIRE
Most Powerful Anti-Aging Product Lines with Patent Pending DNA Complex; Endorsed by Oscars Night 2023 Presenter Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
March 20, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use
March 16, 2023
Via
ACCESSWIRE
CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.
January 17, 2023
Via
ACCESSWIRE
CURE Pharmaceutical Letter to Shareholders
December 15, 2022
Via
ACCESSWIRE
CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
November 22, 2022
Via
ACCESSWIRE
Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding
February 13, 2023
Via
ACCESSWIRE
Nicole Kidman Endorsed Wellness and Beauty Products; On-Track for Accelerated Sales Growth with Company Rebranded as Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
January 20, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
January 19, 2023
Via
ACCESSWIRE
Anti-Aging Wellness Products; Q3 Revenues Surge; $20 Million non-dilutive IP Asset Sale: Cure Pharmaceutical Inc. (Stock Symbol: CURR)
November 28, 2022
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
$20 Million Cash Gain from Partial IP Asset Sale and Strong Financial Growth with Projected Acceleration: CURE Pharmaceutical: (Stock Symbol: CURR)
September 21, 2022
Via
Get News
CURE Pharmaceuticals Holding Corp. (CURR) Featured in Virtual Coverage of NIBA’s 148th Investment Conference
August 30, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Canopy Growth & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About
August 05, 2022
Via
Benzinga
$20 Million sale of IP Platform Technology; Health and Beauty Lines Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
July 29, 2022
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Marketing Partnerships for Advanced Health and Beauty Lines; Products Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
May 10, 2022
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
April 27, 2022
From
Stock News Now
Via
AccessWire
Patented Oral Thin Film Drug Delivery Advancements with Applications on Key Health & Beauty Products; Partnered with Super Star Nicole Kidman: CURE Pharmaceutical (OTCQB: CURR)
January 25, 2022
Via
Get News
Patented Oral Thin Film Drug Delivery Advancements with Applications on Key Health and Beauty Products; Partnered with Super Star Nicole Kidman: CURE Pharmaceutical (OTCQB: CURR)
January 24, 2022
Via
Viz Release
Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne
December 15, 2021
Via
Benzinga
The Week In Cannabis: PharmaCann Could IPO, Tilray & MedMen, First Black CEO At Major Public Co. And More
August 20, 2021
Via
Benzinga
Topics
Cannabis
Initial Public Offering
Exposures
Cannabis
Securities Market
CURE Pharmaceutical Q2 2021 Revenue Spikes 700% After Increased Sales From Seba Labs Products Including A CVS Deal
August 18, 2021
Via
Benzinga
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines
August 17, 2021
From
CURE Pharmaceutical Holding Corp.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.